SEC Form 3
FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 09/25/2021 | 3. Issuer Name and Ticker or Trading Symbol CALIX, INC [ (CALX) ] | |||||||||||||
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option (right to buy) | (1) | 10/01/2027 | Common Stock | 90,000 | 6.95 | D | |
Stock Option (right to buy) | (2) | 12/29/2027 | Common Stock | 126,000 | 5.95 | D | |
Stock Option (right to buy) | (3) | 08/01/2028 | Common Stock | 50,000 | 7 | D | |
Stock Option (right to buy) | (4) | 02/14/2029 | Common Stock | 48,000 | 8.03 | D | |
Stock Option (right to buy) | (5) | 01/31/2030 | Common Stock | 200,000 | 9.16 | D | |
Stock Option (right to buy) | (6) | 01/31/2030 | Common Stock | 50,000 | 9.16 | D |
Explanation of Responses: |
1. 100% of the shares subject to the option grant are fully vested and exercisable. |
2. 100% of the shares subject to the option grant are fully vested and exercisable. |
3. On August 1, 2018, the reporting person was awarded a nonqualified stock option grant covering 50,000 shares of common stock. 25% of the shares subject to the stock option grant vested on August 1, 2019, with the remainder having vested quarterly thereafter in substantially equal installments over the next 36 months, subject to the reporting person's service through each applicable vesting date. As of September 25, 2021, 37,500 shares subject to the option grant are fully vested and exercisable. |
4. On February 14, 2019, the reporting person was awarded a performance-based nonqualified stock option grant covering 160,000 shares of common stock. On February 13, 2020, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 30% of the grant had been achieved. Each nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 13, 2020; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 13, 2020. As of September 25, 2021, 30,000 shares subject to the option grant are fully vested and exercisable. |
5. On January 31, 2020, the reporting person was awarded a performance-based nonqualified stock option grant covering 200,000 shares of common stock. On February 13, 2021, the Compensation Committee of Calix, Inc. determined that the performance criteria governing the grant had been achieved. Each nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on January 31, 2021; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from January 31, 2021. As of September 25, 2021, 75,000 shares subject to the option grant are fully vested and exercisable. |
6. 25% of the shares subject to the stock option grant vested on January 31, 2021, with the remainder vesting quarterly thereafter in substantially equal installments over the next 36 months, subject to the reporting person's service through each applicable vesting date. As of September 25, 2021, 18,750 shares subject to the option grant are fully vested and exercisable. |
Remarks: |
/s/ Tom Gemetti as Attorney-in-fact for Shane Eleniak | 10/04/2021 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |